2026 NPPES data Physical Medicine & Rehabilitation Physician NPI 1528358033 MD
Verify on CMS →

NATALIA COVARRUBIAS-ECKARDT, MD

Physical Medicine & Rehabilitation Physician in BREA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
591
Medicare Part D claims · 161 beneficiaries · Physical Medicine & Rehabilitation Physician avg: 781
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
35.1755/100
▼ 48 pts below national avg 83.1 · [object Object]

What the federal data shows

NATALIA COVARRUBIAS-ECKARDT, MD reported a CMS MIPS final score of 35.1755/100 — below the 83.1 national average — and filed 591 Medicare Part D claims in 2023.

35.1755/100
MIPS score · -48 vs avg
591
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NATALIA COVARRUBIAS-ECKARDT, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

35 3rd percentile higher than 3% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). This entry sits in this band. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NATALIA COVARRUBIAS-ECKARDT, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NATALIA COVARRUBIAS-ECKARDT, MD?

Below national average

NPI registry status

Active

Issued 04/18/2011

NPI 1528358033

Primary specialty

Physical Medicine & Rehabilitation Physician

Mid-sized

15,306 US NPIs in this specialty

Medicare Part D claims

591 24% vs specialty avg

2023 prescription claims

Specialty avg: 781

MIPS final score

35.1755/100 47.924499999999995% pts

Below average band

vs 83.1 national avg

Specialty distribution in California

How Physical Medicine & Rehabilitation Physician compares to other specialties among California providers

California providers

Physical Medicine & Rehabilitation Physician share within California

1. Physical Medicine & Rehabilitation Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Physical Medicine & Rehabilitation Physician share within California

Medicare quality performance — MIPS

NATALIA COVARRUBIAS-ECKARDT, MD's 2023 MIPS final score plotted against the Physical Medicine & Rehabilitation Physician national average

Below national average
MIPS Final Score
35.1755/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Physical Medicine & Rehabilitation Physician) — 35.1755/100 vs national avg 83.1

0%100%National avg83%35.2%
MIPS final score (Physical Medicine & Rehabilitation Physician) — 35.1755/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NATALIA COVARRUBIAS-ECKARDT, MD is a Physical Medicine & Rehabilitation Physician provider practicing in BREA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1528358033. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NATALIA COVARRUBIAS-ECKARDT, MD appears in the CMS NPPES registry as a Physical Medicine & Rehabilitation Physician provider holding MD credentials at 2767 E IMPERIAL HWY, BREA, CA, 92821, with a listed phone of (714) 578-8720. NPI 1528358033 was issued on 04/18/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what COVARRUBIAS-ECKARDT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 591 prescription claims written by this provider, covering 161 Medicare beneficiaries and totaling roughly $85K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 3.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 35.1755/100 for the 2023 performance year (Quality 38.2358, Cost 32.9371), compared with the national average of 83.1.

Physical Medicine & Rehabilitation Physician is a mid-sized specialty nationwide, with 15,306 enrolled providers across 54 states and an average of 781 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2767 E IMPERIAL HWY
BREA, CA 92821

Provider Details

NPI 1528358033
Specialty Physical Medicine & Rehabilitation Physician
Credentials MD
Gender Female
NPI Issued 04/18/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

35.1755
Final Score
Avg: 83.1
38.2358
Quality
32.9371
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where NATALIA COVARRUBIAS-ECKARDT, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COVARRUBIAS REHAB, INC.
FULLERTON, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to NATALIA COVARRUBIAS-ECKARDT, MD. To verify NATALIA COVARRUBIAS-ECKARDT, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NATALIA COVARRUBIAS-ECKARDT, MD — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 591 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

591
Total Claims
$85K
Total Drug Cost
161
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
766
Total Day Supply
21,367
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$74K
Generic Drug Cost
$11K
Opioid Claims
22 (3.7% rate)
Antibiotic Claims
12

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
2.56
Gender Split
52% female / 48% male
Age Distribution
<65: 21, 65-74: 62, 75-84: 58, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
55
Losartan Potassium
26
Gabapentin
25
Amlodipine Besylate
23
Baclofen
22
Levetiracetam
22
Metoprolol Tartrate
21
Clopidogrel
Clopidogrel Bisulfate
19
Botox
Onabotulinumtoxina
17
Eliquis
Apixaban
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Physical Medicine & Rehabilitation Physician Overview

How NATALIA COVARRUBIAS-ECKARDT, MD fits within the Physical Medicine & Rehabilitation Physician landscape nationally.

15,306
Physical Medicine & Rehabilitation Physician Providers in US
54
States with Physical Medicine & Rehabilitation Physician
781
Avg Claims per Provider

NATALIA COVARRUBIAS-ECKARDT, MD's 591 claims are below the specialty average of 781.

Nearby Physical Medicine & Rehabilitation Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as COVARRUBIAS-ECKARDT.

Compare Physical Medicine & Rehabilitation Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NATALIA COVARRUBIAS-ECKARDT, MD's specialty?
NATALIA COVARRUBIAS-ECKARDT, MD specializes in Physical Medicine & Rehabilitation Physician and practices in BREA, California. Credentials: MD.
How much does NATALIA COVARRUBIAS-ECKARDT, MD prescribe under Medicare Part D?
In 2023, NATALIA COVARRUBIAS-ECKARDT, MD wrote 591 Medicare Part D claims totaling $85K in drug costs for 161 beneficiaries.
What is NATALIA COVARRUBIAS-ECKARDT, MD's Medicare quality score?
NATALIA COVARRUBIAS-ECKARDT, MD has a CMS MIPS Final Score of 35.1755/100 (Quality: 38.2358, Cost: 32.9371). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NATALIA COVARRUBIAS-ECKARDT, MD located?
NATALIA COVARRUBIAS-ECKARDT, MD is located at 2767 E IMPERIAL HWY, BREA, CA, 92821. Phone: (714) 578-8720.
What is NATALIA COVARRUBIAS-ECKARDT, MD's NPI number?
NATALIA COVARRUBIAS-ECKARDT, MD's National Provider Identifier (NPI) is 1528358033, issued on 04/18/2011.
Does NATALIA COVARRUBIAS-ECKARDT, MD prescribe more brand-name or generic drugs?
NATALIA COVARRUBIAS-ECKARDT, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $74K in brand drug costs.
Does NATALIA COVARRUBIAS-ECKARDT, MD prescribe opioids?
Yes, NATALIA COVARRUBIAS-ECKARDT, MD had 22 opioid claims in 2023 with an opioid prescribing rate of 3.7%.
How many Physical Medicine & Rehabilitation Physician providers are there in the US?
There are 15,306 Physical Medicine & Rehabilitation Physician providers across 54 states in the US. The average Physical Medicine & Rehabilitation Physician provider writes 781 Medicare Part D claims per year.
What drugs does NATALIA COVARRUBIAS-ECKARDT, MD prescribe most often?
Based on 2023 Medicare Part D data, NATALIA COVARRUBIAS-ECKARDT, MD's most frequently prescribed drugs include Atorvastatin Calcium, Losartan Potassium, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NATALIA COVARRUBIAS-ECKARDT, MD accept Medicare?
NATALIA COVARRUBIAS-ECKARDT, MD appears in CMS Medicare data with 591 Part D claims and 161 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NATALIA COVARRUBIAS-ECKARDT, MD's credentials?
NATALIA COVARRUBIAS-ECKARDT, MD's NPI is 1528358033 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology